Anticonnexin polynucleotides as impaired wound healing compositions

Details for Australian Patent Application No. 2007333535 (hide)

Owner CoDa Therapeutics, Inc.

Inventors Duft, Bradford J.; Becker, David L.; Green, Colin R.

Agent Spruson & Ferguson

Pub. Number AU-A-2007333535

PCT Pub. Number WO2008/073479

Priority 60/874,404 11.12.06 US

Filing date 11 December 2007

Wipo publication date 19 June 2008

International Classifications

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61P 17/02 (2006.01) Drugs for dermatological disorders

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

30 July 2009 PCT application entered the National Phase

  PCT publication WO2008/073479 Priority application(s): WO2008/073479

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007333536-Compounds and compositions as kinase inhibitors

2007333528-Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles